Normobaric Hyperoxia Slows Blood–Brain Barrier Damage and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in Cerebral Ischemia
Stroke (1970), 2015-05, Vol.46 (5), p.1344-1351 [Peer Reviewed Journal]2015 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.114.008599 ;PMID: 25804925
Full text available